CNO insider plans sale of 3,000 shares in Form 144 filing

CNO Financial Group has a planned insider sale of up to 3,000 shares of its common stock, with an aggregate market value of $123,000, as disclosed in a Form 144 notice.

Rhea-AI Filing Summary

CNO Financial Group has a planned insider sale of up to 3,000 shares of its common stock, with an aggregate market value of $123,000, as disclosed in a Form 144 notice. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 11/24/2025. These securities were acquired from the issuer on 01/02/2024 as 1,800 performance shares and 1,200 shares of restricted stock, both fully paid. Shares of CNO common stock outstanding were 95,353,512 as of the figure reported, which serves as a baseline ownership context.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CNO Form 144 filing disclose?

The Form 144 for CNO discloses a planned sale of up to 3,000 shares of CNO common stock by an insider or affiliated holder, providing advance notice of a potential open-market transaction.

How many CNO shares are planned to be sold and what is their market value?

The notice covers up to 3,000 shares of CNO common stock with an aggregate market value of $123,000 based on the price information used in the filing.

When and where are the CNO shares expected to be sold?

The approximate sale date listed is 11/24/2025, and the shares are expected to be sold on the NYSE through Morgan Stanley Smith Barney LLC.

How were the CNO shares being sold under Form 144 originally acquired?

The 3,000 shares were acquired from the issuer on 01/02/2024 as 1,800 performance shares and 1,200 restricted stock, with payment labeled as Not Applicable, consistent with equity awards.

How many CNO common shares are outstanding in relation to this planned sale?

The filing reports 95,353,512 CNO common shares outstanding, providing context for the planned 3,000-share sale size relative to the total equity base.

Which broker is handling the planned CNO share sale under Form 144?

The planned sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, 8th Floor, New York, NY 10004.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/24/2025 - 05:59 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001709782
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CNO FINANCIAL GROUP, INC.
SEC File Number	001-31792
Address of Issuer	11299 Illinois Street Carmel INDIANA 46032
Phone	(317) 817-6100
Name of Person for Whose Account the Securities are To Be Sold	YVONNE K FRANZESE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3000	123000.00	95353512	11/24/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/02/2024	Performance Shares	ISSUER			1800	01/02/2024	Not Applicable
Common	01/02/2024	Restricted Stock	ISSUER			1200	01/02/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/24/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Yvonne Kay Franzese
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)